Inside Medicine at Weill Cornell: the dean as mentor

In the first of a series of Inside Medicine at Weill Cornell videos focusing on mentorship, explore the relationship between Dr. Sarah Bettigole and her mentor, WCMC Dean Dr. Laurie Glimcher.

Surprising factors determine successful aging

The Charter Day Weekend panel "Wellness, Fulfillment and Good Health" focused on ways to lead a healthy, fulfilling life, both physically and mentally.

Epigenome could reverse lymphoma treatment resistance

Weill Cornell Medical College researchers have found an epigenome in cancer cells that may lead to treatment for recurrences after treatment in certain lymphomas.

Weill Cornell video series spotlights culture of mentorship

Weill Cornell Medical College is launching a video series highlighting its culture of mentorship, an essential ingredient of excellent health care, research and education.

Students present their research at 30th CURB forum

Studying everything from potential medicine to the aromatic properties of popular beverages, about 120 undergraduates put project posters on display April 22 at the 30th Annual Spring Research Forum.

Skin-repair startup joins McGovern Center incubator

Repairogen, the newest startup company in the Kevin M. McGovern Family Center for Venture Development incubator, promises to repair sun-damaged skin - and someday possibly prevent skin cancer.

Cell’s protein-making machines shift modes under stress

Cornell researchers have discovered that the cell’s protein-making machinery, called ribosomes, exists in a hybrid form to meet different needs encountered under normal and stressed conditions.

Uniquely human 'pain of altruism' recruits help in childbirth

Human mothers’ experience of pain and the expression of distress occur today because human ancestors who cried for help survived in greater numbers, according a hypothesis by Cornell psychologist Barbara L. Finlay.

Discovery of genetic mutations may lead to lymphoma therapy

An international team of researchers has discovered a pair of genetic mutations that drive tumor growth in patients who have a deadly subtype of T-cell lymphoma. The findings could lead to new targeted therapies for this aggressive disease.